{"product_id":"sitaglu-met-xr-tablets-100mg-1000mg-1-box-28-tablets","title":"Sitaglu Met XR Tablets 100mg\/1000mg (1 Box = 28 Tablets)","description":"\u003cdiv id=\"SPECIFICATION\" class=\"productDescription_descriptionWrapper2__mjUHQ\"\u003e\n\u003ch2 class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__lpzz8 css-9l3uo3\"\u003eSitaglu Met XR Tablets 100\/1000mg (1 Box = 2 Strips) (1 Strip = 7 Tablets) Specification\u003c\/h2\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3___ZqGB\"\u003e\n\u003ch3 class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__y_nDL css-9l3uo3\"\u003eRequires Prescription (YES\/NO)\u003c\/h3\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3___ZqGB\"\u003e\n\u003ch3 class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__y_nDL css-9l3uo3\"\u003eGenerics\u003c\/h3\u003e\n\u003cp\u003eSitagliptin, Metformin\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3___ZqGB\"\u003e\n\u003ch3 class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__y_nDL css-9l3uo3\"\u003eUsed For\u003c\/h3\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3___ZqGB\"\u003e\n\u003ch3 class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__y_nDL css-9l3uo3\"\u003eHow it works\u003c\/h3\u003e\n\u003cp\u003eBy increasing and prolonging active incretin levels, Sitagliptin increases insulin release and decreases glucagon levels in the circulation in a glucose-dependent manner. It is a biguanide with antihyperglycemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycemia.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"USAGE AND SAFETY\" class=\"productDescription_descriptionWrapper2__mjUHQ\"\u003e\n\u003ch2 class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__lpzz8 css-9l3uo3\"\u003eUsage And Safety\u003c\/h2\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3___ZqGB\"\u003e\n\u003ch3 class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__y_nDL css-9l3uo3\"\u003eDosage\u003c\/h3\u003e\n\u003cp\u003eFor patients with type 2 diabetes mellitus, whose hyperglycemic is inadequately controlled with diet and exercise alone, the recommended starting dose of (Sitagliptin + Metformin HCl) is 50mg of Sitagliptin + 500mg of Metformin HCl twice daily. Patients may be titrated upto 50mg Sitagliptin + 1000mg of Metformin HCl twice daily. The dosage of (Sitagliptin + Metformin HCl) should be individualized on the basis of patient’s current regimen, effectiveness and tolerability while not exceeding the maximum recommended daily dose of 100mg Sitagliptin.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3___ZqGB\"\u003e\n\u003ch3 class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__y_nDL css-9l3uo3\"\u003eSide Effects\u003c\/h3\u003e\n\u003cp\u003eCommon: nausea.Uncommon: somnolence, diarrhea, upper abdominal pain and blood glucose decreased.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3___ZqGB\"\u003e\n\u003ch3 class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__y_nDL css-9l3uo3\"\u003eDrug Interactions\u003c\/h3\u003e\n\u003cp\u003eDigoxin , Furosemide , Nifedipine , Cationic drugs (e.g., amiloride, digoxin, morphine, procainamide, quinidine, quinine ranitidine, triamterene, trimethoprim, or vancomycin) , thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3___ZqGB\"\u003e\n\u003ch3 class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__y_nDL css-9l3uo3\"\u003eIndication\u003c\/h3\u003e\n\u003cp\u003eIt is indicated as: - Initial therapy in patients with type 2 diabetes mellitus to improve glycemic control when diet and exercise do not provide adequate glycemic control. As an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus inadequately controlled on Metformin HCl or Sitagliptin alone or in patients already being treated with the combination of Sitagliptin and Metformin HCl.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3___ZqGB\"\u003e\n\u003ch3 class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__y_nDL css-9l3uo3\"\u003eWhen not to Use\u003c\/h3\u003e\n\u003cp\u003eThe combination of Sitagliptin and Metformin HCl is contraindicated in:- Patients with type 1 diabetes. -Patients with known hypersensitivity to Sitagliptin, Metformin HCl or any other component of the product. - Acute or chronic metabolic acidosis , including ketoacidosis, with or without coma.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"PRECAUTIONS\" class=\"productDescription_descriptionWrapper2__mjUHQ\"\u003e\n\u003ch2 class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__lpzz8 css-9l3uo3\"\u003ePrecautions\u003c\/h2\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3___ZqGB\"\u003e\n\u003ch3 class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__y_nDL css-9l3uo3\"\u003ePrecaution\u003c\/h3\u003e\n\u003cp\u003eSitagliptin+Metformin HCl are known to be substantially excreted by the kidney.Metformin HCl-related lactic acidosis increases with the degree of insufficiency of renal function, therefore, serum creatinine concentrations should be determined regularly.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"WARNINGS\" class=\"productDescription_descriptionWrapper2__mjUHQ\"\u003e\n\u003ch2 class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__lpzz8 css-9l3uo3\"\u003eWarnings\u003c\/h2\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3___ZqGB\"\u003e\n\u003ch3 class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__y_nDL css-9l3uo3\"\u003eWarning 1\u003c\/h3\u003e\n\u003cp\u003eSince impaired hepatic function has been associated with some cases of lactic acidosis, Sitagliptin+Metformin HCl should generally be avoided in patients with clinical or laboratory evidence of hepatic disease.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3___ZqGB\"\u003e\n\u003ch3 class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__y_nDL css-9l3uo3\"\u003eWarning 2\u003c\/h3\u003e\n\u003cp\u003ePatient receiving Sitagliptin+Metformin HCl in combination with a sulphonylurea or with insulin may be at risk for hypoglycemia. Therefore, a reduction in the dose of the sulphonylurea or insulin may be necessary.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3___ZqGB\"\u003e\n\u003ch3 class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__y_nDL css-9l3uo3\"\u003eWarning 3\u003c\/h3\u003e\n\u003cp\u003eAfter initiation of Sitagliptin, patients should be observed carefully for signs and symptoms of pancreatitis. If pancreatitis is suspected, Sitagliptin should promptly be discontinued and appropriate management should be initiated.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"ADDITIONAL INFORMATION\" class=\"productDescription_descriptionWrapper2__mjUHQ\"\u003e\n\u003ch2 class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__lpzz8 css-9l3uo3\"\u003eAdditional Information\u003c\/h2\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3___ZqGB\"\u003e\n\u003ch3 class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__y_nDL css-9l3uo3\"\u003ePregnancy category\u003c\/h3\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3___ZqGB\"\u003e\n\u003ch3 class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__y_nDL css-9l3uo3\"\u003eStorage (YES\/NO)\u003c\/h3\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Hilton Pharma","offers":[{"title":"Default Title","offer_id":48044227428582,"sku":null,"price":1676.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0801\/6039\/1398\/files\/images_1_e3a40825-441f-44b9-992e-e993d75b8398.jpg?v=1784986993","url":"https:\/\/www.glitzson.com\/products\/sitaglu-met-xr-tablets-100mg-1000mg-1-box-28-tablets","provider":"Glitzson","version":"1.0","type":"link"}